GLP-1's Made Affordable
Starting at $199
Lose 40lbs easily by
August.

Reasons for being on GLP-1
-
27% lower heart failure risk and 14% fewer heart attacks/strokes through improved blood pressure, cholesterol, and direct vascular protection
-
Slows chronic kidney disease progression by 21%
-
40% slower Parkinson’s progression in early trials and potential Alzheimer’s risk reduction
-
63% reduction in breathing pauses through weight loss and direct airway muscle effects
-
Lowers diabetes risk by 60% through improved insulin sensitivity
28
lbsHear from MdSide Doctors
MdSide Board-certified physician's explaining GLP-1
medication and its positive
impact on long-term health















Compounded semaglutide and Tirzepatide
Start with a free, no-obligation evaluation — only pay if treatment is right for you.
If prescribed, subscription plans start at $199/mo, including:
Healthcare Provider Visits
Medication and Supplies
Shipping to Your Door
No Insurance Required



Tell us more about your health
Is there any specific medical circumstance affecting your health currently or in the past?
The results speak for themselves.
GLP-1’s were approved by the FDA in 2005. Not only do we understand the safety, but there are also countless publications citing the positive effects of the medication.
48lbs lost in 5 months
119lbs lost in 13 months
42lbs lost in 4 months
48lbs lost in 5 months
119lbs lost in 13 months
42lbs lost in 4 months
Real members, real weight loss results
Don't just take it from us – our members see (and feel) the difference.
87% have seen life-changing results
93% agree MDside is easier to incorporate into their lives
97% report silenced or quieter food noise since starting

American Association for the Advancement of Science
Innovators who fought to unlock GLP-1 drugs for obesity were awarded breakthrough of the year award.

PubMed Central®
By taking semaglutide, participants achieved an average of 14.9% body weight loss.

National Library of Medicine
Oral semaglutide has shown impressive results in clinical trials, achieving an average 1.5% reduction in HbA1c
*These findings are based on FDA-approved drugs and do not apply to compounded formulations.
Potency test
Learn more
Sterility test
Learn more
pH test
Learn more
Endotoxicity
Learn more

The better way to lose weight
Join 500,000+ weight loss patients
Finally serious about weight loss? Lose 40 lbs by July with GLP-1 medication
-
Lose pounds of fat every week
-
Personalized Care: Highly effective GLP-1 medications
-
No membership fees! Everything you need is included
-
Start for just $179, no insurance required + free shipping



500+ satisfied customers
patients every month
Care for everyone
& customer support
appointments needed
500+ satisfied customers
patients every month
Care for everyone
& customer support
appointments needed
Lower BMIs lead to total improved health
GLP-1’s were approved by the FDA in 2005. Not only do we understand the safety, but there are also countless publications citing the positive effects of the medication.
14.9%
Participants in studies with semaglutide experienced an average weight loss of 14.9% over 68 weeks.
90%
In clinical studies, up to 90% of patients using GLP-1 agonists achieved HbA1c targets below 7%.
26%
The use of semaglutide has been associated with a 26% reduction in cardiovascular-related deaths.